Company intelligence
BIOMEX
Your 360° Partner for Life Sciences and Diagnostics – Unlock your full potential with us.
About BIOMEX
BIOMEX is Europe’s leading supplier of human biospecimens for the diagnostics and life sciences industries. With more than 30 years of experience, we can provide you with all kinds of human biosamples, such as blood, disease state plasma, tissue blocks, and much more. For the pharmaceutical industry and R&D we provide a wide range of services, such as biospecimen processing, cell-based assays, sequencing services or cell isolation. Furthermore, we are a well-established partner for the IvD industry in the development, validation, registration and manufacturing of in-vitro diagnostics. From serving as an external storage or study site to organizing and complete external studies: With our holistic approach you will save time to market – of course, everything in accordance with the current regulations (IVDR). Do you have a special inquiry? A major part of our material is sourced in our own donor centers in Heidelberg, Munich and Cameroon (mobile center). Besides this, we have an extensive network including laboratories, study sites and medical experts, and cover fields such as infectious diseases, oncology, hematology, endocrinology and immunology.
Verified activity
Signals from BIOMEX
4 published signals
Research & Knowledge
BIOMEX supported the development and validation of SARS-CoV-2 serological assays in multiple peer-reviewed studies using well-characterized COVID-19 blood samples.
Reported by BIOMEX
Research & Knowledge
BIOMEX specimens were used to evaluate a quantitative neutralizing antibody assay in another study demonstrating 99.6% sensitivity and 99.6% specificity.
Reported by BIOMEX
Research & Knowledge
BIOMEX samples contributed to the performance of an automated chemiluminescence assay with 100% sensitivity and 100% specificity.
Reported by BIOMEX
Research & Knowledge
BIOMEX conducted independent work with seroconversion panels to highlight the importance of well-characterized clinical samples for robust SARS-CoV-2 serological assay validation.
Reported by BIOMEX